{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:57:34Z","timestamp":1790639854973,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFAG-24872"],"award-info":[{"award-number":["MFAG-24872"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFAG-26038"],"award-info":[{"award-number":["MFAG-26038"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","award":["682295"],"award-info":[{"award-number":["682295"]}],"id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","award":["920495"],"award-info":[{"award-number":["920495"]}],"id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alpha-1 antitrypsin (AAT) is a serine protease inhibitor that protects tissue from neutrophil elastase and other proteases, particularly in the lung. Mutations in\n                    <jats:italic>SERPINA1<\/jats:italic>\n                    , including the Z mutation, lead to AAT deficiency (AATD), characterized by reduced circulating AAT and increased risk of pulmonary emphysema, liver cirrhosis, and hepatocellular carcinoma. Beyond these well-characterized manifestations, AATD has been associated with panniculitis, rheumatoid arthritis, and glomerulonephritis. Emerging evidence has also suggested a link between AATD and inflammatory bowel diseases (IBDs), although experimental validation is lacking. In this study, we demonstrate that PiZ transgenic mice expressing the polymer-forming ATZ display increased susceptibility to dextran sodium sulfate (DSS)-induced colitis, accompanied by marked Paneth cell abnormalities. The accumulation of polymeric ATZ in Paneth cells is associated with the endoplasmic reticulum (ER) stress response, impaired lysosomal clearance, altered association of Lysozyme-1 (Lyz1) with LC3-containing compartments, and increased Lyz1 secretion. These intestinal alterations were accompanied by changes in microbiota composition, whereas DSS exposure and exogenous lysozyme administration were associated with aggravated intestinal and hepatic pathology. Pharmacological inhibition of ER stress restored crypt homeostasis and normalized Lyz1 secretion. Human Pi*ZZ iPSC-derived intestinal organoids similarly showed ATZ polymer accumulation in secretory epithelial cells and transcriptional alterations involving ER protein processing and epithelial homeostasis. In addition, polymeric ATZ was detected in ileal crypts from a single individual with AATD and intestinal disease. Together, our data reveal a Paneth cell-intrinsic ER stress mechanism linking ATZ accumulation to gut epithelial dysfunction, highlighting a previously underexplored role of the gut\u2013liver axis in AATD.\n                  <\/jats:p>","DOI":"10.1038\/s41392-026-02925-9","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:01:54Z","timestamp":1790636514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polymeric alpha-1 antitrypsin perturbs Paneth cell proteostasis and exacerbates intestinal inflammation"],"prefix":"10.1038","volume":"11","author":[{"given":"Francesco","family":"Annunziata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-4303","authenticated-orcid":false,"given":"Felipe","family":"Dos Santos Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Relvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Maria","family":"Custode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Raiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-8692","authenticated-orcid":false,"given":"Rossella","family":"De Cegli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-9021","authenticated-orcid":false,"given":"Eugenio","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Compare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-1974","authenticated-orcid":false,"given":"Francesco","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-5592","authenticated-orcid":false,"given":"Nunzia","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2925_CR1","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","volume":"360","author":"EK Silverman","year":"2009","unstructured":"Silverman, E. K. & Sandhaus, R. A. Clinical practice. Alpha1-antitrypsin deficiency. N. Engl. J. Med. 360, 2749\u20132757 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2925_CR2","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1378\/chest.122.5.1818","volume":"122","author":"FJ de Serres","year":"2002","unstructured":"de Serres, F. J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122, 1818\u20131829 (2002).","journal-title":"Chest"},{"key":"2925_CR3","doi-asserted-by":"publisher","first-page":"33293","DOI":"10.1074\/jbc.R100016200","volume":"276","author":"GA Silverman","year":"2001","unstructured":"Silverman, G. A. et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293\u201333296 (2001).","journal-title":"J. Biol. Chem."},{"key":"2925_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/JCI113580","volume":"82","author":"JA Carlson","year":"1988","unstructured":"Carlson, J. A. et al. Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J. Clin. Investig. 82, 26\u201336 (1988).","journal-title":"J. Clin. Investig."},{"key":"2925_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/nar\/15.4.1459","volume":"15","author":"RN Sifers","year":"1987","unstructured":"Sifers, R. N. et al. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res. 15, 1459\u20131475 (1987).","journal-title":"Nucleic Acids Res."},{"key":"2925_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1172\/JCI113999","volume":"83","author":"JA Carlson","year":"1989","unstructured":"Carlson, J. A. et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J. Clin. Investig. 83, 1183\u20131190 (1989).","journal-title":"J. Clin. Investig."},{"key":"2925_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2012.00107","volume":"3","author":"DC Rubin","year":"2012","unstructured":"Rubin, D. C., Shaker, A. & Levin, M. S. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front. Immunol. 3, 107 (2012).","journal-title":"Front. Immunol."},{"key":"2925_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fimmu.2015.00551","volume":"6","author":"I Loddo","year":"2015","unstructured":"Loddo, I. & Romano, C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front. Immunol. 6, 551 (2015).","journal-title":"Front. Immunol."},{"key":"2925_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00054725-199911000-00002","volume":"5","author":"AN Elzouki","year":"1999","unstructured":"Elzouki, A. N. et al. The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm. Bowel Dis. 5, 246\u2013252 (1999).","journal-title":"Inflamm. Bowel Dis."},{"key":"2925_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.rmed.2013.10.006","volume":"108","author":"H Stone","year":"2014","unstructured":"Stone, H., Pye, A. & Stockley, R. A. Disease associations in alpha-1-antitrypsin deficiency. Respir. Med. 108, 338\u2013343 (2014).","journal-title":"Respir. Med."},{"issue":"Suppl 1","key":"2925_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15412555.2015.1021909","volume":"12","author":"E Piitulainen","year":"2015","unstructured":"Piitulainen, E. & Tanash, H. A. The clinical profile of subjects included in the Swedish national register on individuals with severe alpha 1-antitrypsin deficiency. COPD 12(Suppl 1), 36\u201341 (2015).","journal-title":"COPD"},{"key":"2925_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0025-6196(11)64212-2","volume":"75","author":"P Yang","year":"2000","unstructured":"Yang, P., Tremaine, W. J., Meyer, R. L. & Prakash, U. B. Alpha1-antitrypsin deficiency and inflammatory bowel diseases. Mayo Clin. Proc. 75, 450\u2013455 (2000).","journal-title":"Mayo Clin. Proc."},{"key":"2925_CR13","doi-asserted-by":"crossref","unstructured":"Hiller, A. M. et al. Severe alpha(1)-antitrypsin deficiency and increased risk of gastrointestinal diseases. Mayo Clin. Proc. (2026). Online ahead of print.","DOI":"10.1016\/j.mayocp.2025.11.017"},{"key":"2925_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.biocel.2005.09.021","volume":"38","author":"D Subramaniyam","year":"2006","unstructured":"Subramaniyam, D. et al. C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int. J. Biochem. Cell Biol. 38, 563\u2013575 (2006).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2925_CR15","doi-asserted-by":"publisher","first-page":"769718","DOI":"10.3389\/fphar.2021.769718","volume":"12","author":"P Qiu","year":"2021","unstructured":"Qiu, P. et al. Identification of pharmacological autophagy regulators of active ulcerative colitis. Front. Pharmacol. 12, 769718 (2021).","journal-title":"Front. Pharmacol."},{"key":"2925_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577 (2020).","journal-title":"J. Hepatol."},{"key":"2925_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nature12599","volume":"503","author":"TE Adolph","year":"2013","unstructured":"Adolph, T. E. et al. Paneth cells as a site of origin for intestinal inflammation. Nature 503, 272\u2013276 (2013).","journal-title":"Nature"},{"key":"2925_CR18","doi-asserted-by":"crossref","unstructured":"Khodayari, N. et al. The mechanism of mitochondrial injury in alpha-1 antitrypsin deficiency mediated liver disease. Int. J. Mol. Sci. 22, 13255 (2021).","DOI":"10.3390\/ijms222413255"},{"key":"2925_CR19","doi-asserted-by":"publisher","first-page":"15 25 11","DOI":"10.1002\/0471142735.im1525s104","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol. 104, 15 25 11\u201315 25 14 (2014).","journal-title":"Curr. Protoc. Immunol."},{"key":"2925_CR20","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1097\/MIB.0b013e3182802c6a","volume":"19","author":"CB Collins","year":"2013","unstructured":"Collins, C. B. et al. Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm. Bowel Dis. 19, 1964\u20131973 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"2925_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104202","volume":"25","author":"D Sirvinskas","year":"2022","unstructured":"Sirvinskas, D. et al. Single-cell atlas of the aging mouse colon. iScience 25, 104202 (2022).","journal-title":"iScience"},{"key":"2925_CR22","first-page":"700","volume":"123","author":"A Couturier-Maillard","year":"2013","unstructured":"Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Investig. 123, 700\u2013711 (2013).","journal-title":"J. Clin. Investig."},{"key":"2925_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.cell.2008.07.021","volume":"134","author":"A Kaser","year":"2008","unstructured":"Kaser, A. et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134, 743\u2013756 (2008).","journal-title":"Cell"},{"key":"2925_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2010.05.009","volume":"141","author":"K Cadwell","year":"2010","unstructured":"Cadwell, K. et al. Virus-plus-susceptibility gene interaction determines Crohn\u2019s disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135\u20131145 (2010).","journal-title":"Cell"},{"key":"2925_CR25","first-page":"258","volume":"5","author":"JE Kaserman","year":"2018","unstructured":"Kaserman, J. E. & Wilson, A. A. Patient-derived induced pluripotent stem cells for alpha-1 antitrypsin deficiency disease modeling and therapeutic discovery. Chronic Obstr. Pulm. Dis. 5, 258\u2013266 (2018).","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"2925_CR26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/nprot.2011.410","volume":"6","author":"KW McCracken","year":"2011","unstructured":"McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920\u20131928 (2011).","journal-title":"Nat. Protoc."},{"key":"2925_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12938\/bmfh.2015-019","volume":"35","author":"K Nakamura","year":"2016","unstructured":"Nakamura, K., Sakuragi, N., Takakuwa, A. & Ayabe, T. Paneth cell alpha-defensins and enteric microbiota in health and disease. Biosci. Microbiota Food Health 35, 57\u201367 (2016).","journal-title":"Biosci. Microbiota Food Health"},{"key":"2925_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/gut.2007.142588","volume":"57","author":"LA Simms","year":"2008","unstructured":"Simms, L. A. et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn\u2019s disease. Gut 57, 903\u2013910 (2008).","journal-title":"Gut"},{"key":"2925_CR29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4049\/jimmunol.179.2.1245","volume":"179","author":"J Shi","year":"2007","unstructured":"Shi, J. et al. A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J. Immunol. 179, 1245\u20131253 (2007).","journal-title":"J. Immunol."},{"key":"2925_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.immuni.2020.07.010","volume":"53","author":"S Yu","year":"2020","unstructured":"Yu, S. et al. Paneth cell-derived lysozyme defines the composition of mucolytic microbiota and the inflammatory tone of the intestine. Immunity 53, 398\u2013416.e8 (2020).","journal-title":"Immunity"},{"key":"2925_CR31","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.aal4677","volume":"357","author":"S Bel","year":"2017","unstructured":"Bel, S. et al. Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine. Science 357, 1047\u20131052 (2017).","journal-title":"Science"},{"key":"2925_CR32","doi-asserted-by":"publisher","first-page":"154969","DOI":"10.1016\/j.prp.2023.154969","volume":"253","author":"G Zhu","year":"2024","unstructured":"Zhu, G. et al. Suppression of endoplasmic reticulum stress by 4-PBA enhanced atherosclerotic plaque stability via up-regulating CLOCK expression. Pathol. Res. Pract. 253, 154969 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"2925_CR33","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1002\/hep4.1997","volume":"6","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocellular and murine models. Hepatol. Commun. 6, 2354\u20132367 (2022).","journal-title":"Hepatol. Commun."},{"key":"2925_CR34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ibd.20848","volume":"15","author":"K Bielefeldt","year":"2009","unstructured":"Bielefeldt, K., Davis, B. & Binion, D. G. Pain and inflammatory bowel disease. Inflamm. Bowel Dis. 15, 778\u2013788 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"2925_CR35","doi-asserted-by":"crossref","unstructured":"Calvez, V. et al. Novel insights into the pathogenesis of inflammatory bowel diseases. Biomedicines 13, 305 (2025).","DOI":"10.3390\/biomedicines13020305"},{"key":"2925_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00408-007-9009-y","volume":"185","author":"AT Mulgrew","year":"2007","unstructured":"Mulgrew, A. T., Taggart, C. C. & McElvaney, N. G. Alpha-1-antitrypsin deficiency: current concepts. Lung 185, 191\u2013201 (2007).","journal-title":"Lung"},{"key":"2925_CR37","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1172\/JCI116797","volume":"92","author":"EP Molmenti","year":"1993","unstructured":"Molmenti, E. P., Perlmutter, D. H. & Rubin, D. C. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J. Clin. Investig. 92, 2022\u20132034 (1993).","journal-title":"J. Clin. Investig."},{"key":"2925_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40139-017-0147-5","volume":"5","author":"EL Mitchell","year":"2017","unstructured":"Mitchell, E. L. & Khan, Z. Liver disease in alpha-1 antitrypsin deficiency: current approaches and future directions. Curr. Pathobiol. Rep. 5, 243\u2013252 (2017).","journal-title":"Curr. Pathobiol. Rep."},{"key":"2925_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2337\/db06-1273","volume":"56","author":"B Zhang","year":"2007","unstructured":"Zhang, B. et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 56, 1316\u20131323 (2007).","journal-title":"Diabetes"},{"key":"2925_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1189\/jlb.0208145","volume":"85","author":"GB Pott","year":"2009","unstructured":"Pott, G. B., Chan, E. D., Dinarello, C. A. & Shapiro, L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85, 886\u2013895 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"2925_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/labinvest.3780324","volume":"81","author":"A Churg","year":"2001","unstructured":"Churg, A. et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Investig. 81, 1119\u20131131 (2001).","journal-title":"Lab. Investig."},{"key":"2925_CR42","doi-asserted-by":"publisher","first-page":"16242","DOI":"10.1073\/pnas.0808031105","volume":"105","author":"M Koulmanda","year":"2008","unstructured":"Koulmanda, M. et al. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. USA. 105, 16242\u201316247 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2925_CR43","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.1073\/pnas.0505579102","volume":"102","author":"EC Lewis","year":"2005","unstructured":"Lewis, E. C., Shapiro, L., Bowers, O. J. & Dinarello, C. A. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. USA. 102, 12153\u201312158 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2925_CR44","doi-asserted-by":"publisher","first-page":"16236","DOI":"10.1073\/pnas.0807627105","volume":"105","author":"EC Lewis","year":"2008","unstructured":"Lewis, E. C. et al. alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. USA. 105, 16236\u201316241 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2925_CR45","doi-asserted-by":"publisher","unstructured":"Jeshvaghani, Z. S. et al. A collection of patient-derived intestinal organoid lines reveals epithelial phenotypes associated with genetic drivers of pediatric inflammatory bowel disease. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.11.659052 (2025).","DOI":"10.1101\/2025.06.11.659052"},{"key":"2925_CR46","doi-asserted-by":"publisher","first-page":"1425610","DOI":"10.3389\/fimmu.2024.1425610","volume":"15","author":"J Kang","year":"2024","unstructured":"Kang, J. et al. Association between inflammatory bowel disease and osteoporosis in European and East Asian populations: exploring causality, mediation by nutritional status, and shared genetic architecture. Front. Immunol. 15, 1425610 (2024).","journal-title":"Front. Immunol."},{"key":"2925_CR47","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AM Choi","year":"2013","unstructured":"Choi, A. M., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845\u20131846 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2925_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature07416","volume":"456","author":"K Cadwell","year":"2008","unstructured":"Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259\u2013263 (2008).","journal-title":"Nature"},{"key":"2925_CR49","doi-asserted-by":"crossref","unstructured":"Iida, T., Onodera, K. & Nakase, H. Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 23, 1944\u20131953 (2017).","DOI":"10.3748\/wjg.v23.i11.1944"},{"key":"2925_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411, 599\u2013603 (2001).","journal-title":"Nature"},{"key":"2925_CR51","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1084\/jem.20170558","volume":"214","author":"Y Matsuzawa-Ishimoto","year":"2017","unstructured":"Matsuzawa-Ishimoto, Y. et al. Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium. J. Exp. Med. 214, 3687\u20133705 (2017).","journal-title":"J. Exp. Med."},{"key":"2925_CR52","first-page":"34","volume":"39","author":"JH Teckman","year":"2004","unstructured":"Teckman, J. H. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J. Pediatr. Gastroenterol. Nutr. 39, 34\u201337 (2004).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2925_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1009113","volume":"13","author":"A Albanese","year":"2022","unstructured":"Albanese, A. et al. Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol. Front. Neurol. 13, 1009113 (2022).","journal-title":"Front. Neurol."},{"key":"2925_CR54","doi-asserted-by":"publisher","first-page":"e5391","DOI":"10.1097\/MD.0000000000005391","volume":"95","author":"H Ma","year":"2016","unstructured":"Ma, H. et al. A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine 95, e5391 (2016).","journal-title":"Medicine"},{"key":"2925_CR55","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2337\/db10-0308","volume":"59","author":"M Kars","year":"2010","unstructured":"Kars, M. et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59, 1899\u20131905 (2010).","journal-title":"Diabetes"},{"key":"2925_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ene.12664","volume":"23","author":"AE Elia","year":"2016","unstructured":"Elia, A. E. et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 23, 45\u201352 (2016).","journal-title":"Eur. J. Neurol."},{"key":"2925_CR57","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/hep.21689","volume":"46","author":"SD Miller","year":"2007","unstructured":"Miller, S. D. et al. Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad. Hepatology 46, 496\u2013503 (2007).","journal-title":"Hepatology"},{"key":"2925_CR58","doi-asserted-by":"publisher","first-page":"G1050","DOI":"10.1152\/ajpgi.00393.2003","volume":"286","author":"LL Clarke","year":"2004","unstructured":"Clarke, L. L. et al. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G1050\u2013G1058 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2925_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39398-1","volume":"14","author":"R Song","year":"2023","unstructured":"Song, R. et al. Trans-Golgi protein TVP23B regulates host-microbe interactions via Paneth cell homeostasis and Goblet cell glycosylation. Nat. Commun. 14, 3652 (2023).","journal-title":"Nat. Commun."},{"key":"2925_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00018-023-04948-9","volume":"80","author":"G Liu","year":"2023","unstructured":"Liu, G. et al. Amyloid-beta mediates intestinal dysfunction and enteric neurons loss in Alzheimer\u2019s disease transgenic mouse. Cell Mol. Life Sci. 80, 351 (2023).","journal-title":"Cell Mol. Life Sci."},{"key":"2925_CR61","doi-asserted-by":"crossref","unstructured":"Wu, S., Yi, J., Zhang, Y.-G., Zhou, J. & Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3, e12356 (2015).","DOI":"10.14814\/phy2.12356"},{"key":"2925_CR62","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s00018-008-8182-3","volume":"65","author":"S Mukherjee","year":"2008","unstructured":"Mukherjee, S., Vaishnava, S. & Hooper, L. V. Multi-layered regulation of intestinal antimicrobial defense. Cell. Mol. Life Sci. 65, 3019\u20133027 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"2925_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109466","volume":"113","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. The role of NOD2 in intestinal immune response and microbiota modulation: a therapeutic target in inflammatory bowel disease. Int. Immunopharmacol. 113, 109466 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2925_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0035-1571276","volume":"36","author":"G Anand","year":"2016","unstructured":"Anand, G., Zarrinpar, A. & Loomba, R. Targeting dysbiosis for the treatment of liver disease. Semin. Liver Dis. 36, 37\u201347 (2016).","journal-title":"Semin. Liver Dis."},{"key":"2925_CR65","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.livres.2019.09.001","volume":"3","author":"F Li","year":"2019","unstructured":"Li, F., McClain, C. J. & Feng, W. Microbiome dysbiosis and alcoholic liver disease(\u2606). Liver Res. 3, 218\u2013226 (2019).","journal-title":"Liver Res."},{"key":"2925_CR66","first-page":"233","volume":"20","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. Lysozyme promotes renal fibrosis through the JAK\/STAT3 signal pathway in diabetic nephropathy. Arch. Med. Sci. 20, 233\u2013247 (2024).","journal-title":"Arch. Med. Sci."},{"key":"2925_CR67","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1988836","volume":"13","author":"IS Larsen","year":"2021","unstructured":"Larsen, I. S. et al. Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis. Gut Microbes 13, 1988836 (2021).","journal-title":"Gut Microbes"},{"key":"2925_CR68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/emmm.201202046","volume":"5","author":"N Pastore","year":"2013","unstructured":"Pastore, N. et al. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol. Med. 5, 397\u2013412 (2013).","journal-title":"EMBO Mol. Med."},{"key":"2925_CR69","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","volume":"1559","author":"YO Kim","year":"2017","unstructured":"Kim, Y. O., Popov, Y. & Schuppan, D. Optimized mouse models for liver fibrosis. Methods Mol. Biol. 1559, 279\u2013296 (2017).","journal-title":"Methods Mol. Biol."},{"key":"2925_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2925_CR71","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/s41596-022-00738-y","volume":"17","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. Metagenome analysis using the Kraken software suite. Nat. Protoc. 17, 2815\u20132839 (2022).","journal-title":"Nat. Protoc."},{"key":"2925_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02925-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:01:59Z","timestamp":1790636519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02925-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2925"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02925-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"414"}}